GlobeNewswire·Mar 3, 2026, 8:00 AM ET

Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

EBS

Emergent BioSolutions Inc. appointed John D. Fowler, Jr. to its board of directors effective March 1, 2026.
Fowler brings over three decades of leadership experience in the healthcare & financial services sectors.
He will serve on the company's Audit & Finance Committee.
Chairman Dr. Zsolt Harsanyi highlighted Fowler's value for the company's turnaround & transformation.
Fowler currently chairs the board of trustees of the University of Virginia Darden School Foundation.
He spent 14 years at Wells Fargo Securities in senior roles, including vice chairman of Corporate & Investment Banking.
Previous executive roles include vice chairman at Deutsche Bank, head of Health Care Services Banking at JPMorgan, & head of Health Care Banking at Salomon Brothers.
His biotech & private equity experience includes serving as president of Large Scale Biology Corporation, founding partner of Bio-Strategic Directors, & managing partner of Baycrest Capital.
Fowler has held board seats at Beverly Enterprises, Large Scale Biology Corporation, & Optical Dynamics.
He holds a Juris Doctor from the University of Virginia School of Law, an MBA from the University of Virginia Darden School of Business, & a Bachelor of Arts in History from the University of Virginia.
Emergent BioSolutions focuses on delivering life-saving solutions for health threats such as smallpox, mpox, botulism, Ebola, anthrax, & opioid overdose emergencies.
The press release includes standard forward-looking statements & disclaimers under the Private Securities Litigation Reform Act of 1995.